BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
7/1/2024 6:03:24 AM | Browse: 216 | Download: 487
 |
Received |
|
2024-04-07 13:21 |
|
Peer-Review Started |
|
2024-04-07 13:21 |
|
First Decision by Editorial Office Director |
|
2024-04-30 09:08 |
|
Return for Revision |
|
2024-04-30 09:08 |
|
Revised |
|
2024-05-23 14:47 |
 |
Publication Fee Transferred |
|
|
|
Second Decision by Editor |
|
2024-06-03 02:44 |
|
Second Decision by Editor-in-Chief |
|
|
|
Final Decision by Editorial Office Director |
|
2024-06-03 10:00 |
|
Articles in Press |
|
2024-06-03 10:00 |
|
Edit the Manuscript by Language Editor |
|
2024-06-16 17:56 |
|
Typeset the Manuscript |
|
2024-06-27 08:29 |
|
Publish the Manuscript Online |
|
2024-07-01 06:03 |
| ISSN |
2307-8960 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
| Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
| Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
| Category |
Oncology |
| Manuscript Type |
Case Report |
| Article Title |
Advanced lung adenocarcinoma with EGFR 19-del mutation transformed into squamous cell carcinoma after EGFR-tyrosine kinase inhibitors treatment: A case report
|
| Manuscript Source |
Unsolicited Manuscript |
| All Author List |
Xing-Zu Ji, Zhong-Da Liu, Yi-Ping Ye, Quan Li, Xiao-Jing Liu, Min-Hua Zhou and Yi Jin |
| ORCID |
|
| Funding Agency and Grant Number |
|
| Corresponding Author |
Yi Jin, BMed, Attending Doctor, Department of Emergency Medicine, Lishui People's Hospital, No. 15 Mass Street, Liandu District, Lishui 323000, Zhejiang Province, China. 15990421805@163.com |
| Key Words |
Lung adenocarcinoma; Squamous cell carcinoma; Pathological histological transformation; Epidermal growth factor receptor tyrosine kinase inhibitor; Drug resistance; Case report |
| Core Tip |
Patients inevitably encounter drug resistance issues after receiving epidermal growth factor receptor tyrosine kinase inhibitor (EGFR-TKI) treatment; EGFR-TKI resistance can be divided into primary and acquired. Pathological transformation is one of the mechanisms of acquired resistance in EGFR-TKIs, with squamous cell carcinoma transformation being relatively rare. This study provides detailed insights into a 67-year-old female patient with EGFR 19-del mutation in advanced lung adenocarcinoma who developed drug resistance after treatment with EGFR-TKIs. Our results provide a detailed analysis of the patient’s diagnosis and treatment process, alongside a review of literature on squamous cell carcinoma transformation after EGFR-TKI treatment for lung adenocarcinoma. |
| Publish Date |
2024-07-01 06:03 |
| Citation |
Ji XZ, Liu ZD, Ye YP, Li Q, Liu XJ, Zhou MH, Jin Y. Advanced lung adenocarcinoma with EGFR 19-del mutation transformed into squamous cell carcinoma after EGFR-tyrosine kinase inhibitors treatment: A case report. World J Clin Cases 2024; 12(20): 4405-4411 |
| URL |
https://www.wjgnet.com/2307-8960/full/v12/i20/4405.htm |
| DOI |
https://dx.doi.org/10.12998/wjcc.v12.i20.4405 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345
